Bluestone Pharma

Bluestone Pharma is a Swiss specialty pharmaceutical company dedicated to the development and licensing of innovative therapeutic solutions, with a core focus on bone health and women's medicine. The company is best known for its expertise in Vitamin D3 (colecalciferol) formulations, having developed the successful Fultium-D3 product line used for the prevention and treatment of Vitamin D deficiency and osteoporosis. Bluestone Pharma operates a lean business model, leveraging strategic partnerships for the international distribution and commercialization of its portfolio. By focusing on niche therapeutic areas and optimized drug delivery, the company aims to address unmet medical needs in endocrinology. Their headquarters are located in Inwil, Switzerland, where they manage their global intellectual property and licensing activities.